世界の顕微鏡的多発血管炎（MPA）治療市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Microscopic Polyangiitis(MPA) Treatment Market Size, Status and Forecast 2021-2027

• レポートコード：QFJ1-4506
• 出版社/出版日：QYResearch / 2021年6月
※2024年版があります。お問い合わせください。
• レポート形態：英文、PDF、100ページ
• 納品方法：Eメール（納期：3日）
• 産業分類：医療

• 販売価格（消費税別）

Single User	￥585,000 (USD3,900)	▷ お問い合わせ
Multi User	￥877,500 (USD5,850)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

QYResearch社発行の本調査レポートでは、顕微鏡的多発血管炎（MPA）治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（アバコパン、免疫グロブリン、リツキシマブバイオシミラー、その他）、用途別市場規模（病院、クリニック、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。
・市場概要
・顕微鏡的多発血管炎（MPA）治療の市場動向
・企業の競争状況、市場シェア
・顕微鏡的多発血管炎（MPA）治療の種類別市場規模と予測2016-2027（アバコパン、免疫グロブリン、リツキシマブバイオシミラー、その他）
・顕微鏡的多発血管炎（MPA）治療の用途別市場規模と予測2016-2027（病院、クリニック、その他）
・顕微鏡的多発血管炎（MPA）治療の北米市場規模2016-2027（アメリカ、カナダ）
・顕微鏡的多発血管炎（MPA）治療の欧州市場規模2016-2027（ドイツ、フランス、イギリス等）
・顕微鏡的多発血管炎（MPA）治療のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等）
・顕微鏡的多発血管炎（MPA）治療の中南米市場規模2016-2027（メキシコ、ブラジル）
・顕微鏡的多発血管炎（MPA）治療の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等）
・主要企業情報（Celltrion Inc、ChemoCentryx Inc、Sandoz International GmbH、Teijin Pharma Ltd、TTY Biopharm Company Ltd）
・結論

Market Analysis and Insights: Global Microscopic Polyangiitis(MPA) Treatment Market
The global Microscopic Polyangiitis(MPA) Treatment market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Microscopic Polyangiitis(MPA) Treatment market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Microscopic Polyangiitis(MPA) Treatment market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Microscopic Polyangiitis(MPA) Treatment market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Microscopic Polyangiitis(MPA) Treatment market.

Global Microscopic Polyangiitis(MPA) Treatment Scope and Market Size
Microscopic Polyangiitis(MPA) Treatment market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Microscopic Polyangiitis(MPA) Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Avacopan
Immune Globulin
Rituximab Biosimilar
Others

Segment by Application
Hospital
Clinic
Others

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Celltrion Inc
ChemoCentryx Inc
Sandoz International GmbH
Teijin Pharma Ltd
TTY Biopharm Company Ltd

レポート目次

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Microscopic Polyangiitis(MPA) Treatment Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Avacopan
1.2.3 Immune Globulin
1.2.4 Rituximab Biosimilar
1.2.5 Others
1.3 Market by Application
1.3.1 Global Microscopic Polyangiitis(MPA) Treatment Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Microscopic Polyangiitis(MPA) Treatment Market Perspective (2016-2027)
2.2 Microscopic Polyangiitis(MPA) Treatment Growth Trends by Regions
2.2.1 Microscopic Polyangiitis(MPA) Treatment Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Microscopic Polyangiitis(MPA) Treatment Historic Market Share by Regions (2016-2021)
2.2.3 Microscopic Polyangiitis(MPA) Treatment Forecasted Market Size by Regions (2022-2027)
2.3 Microscopic Polyangiitis(MPA) Treatment Industry Dynamic
2.3.1 Microscopic Polyangiitis(MPA) Treatment Market Trends
2.3.2 Microscopic Polyangiitis(MPA) Treatment Market Drivers
2.3.3 Microscopic Polyangiitis(MPA) Treatment Market Challenges
2.3.4 Microscopic Polyangiitis(MPA) Treatment Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Microscopic Polyangiitis(MPA) Treatment Players by Revenue
3.1.1 Global Top Microscopic Polyangiitis(MPA) Treatment Players by Revenue (2016-2021)
3.1.2 Global Microscopic Polyangiitis(MPA) Treatment Revenue Market Share by Players (2016-2021)
3.2 Global Microscopic Polyangiitis(MPA) Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Microscopic Polyangiitis(MPA) Treatment Revenue
3.4 Global Microscopic Polyangiitis(MPA) Treatment Market Concentration Ratio
3.4.1 Global Microscopic Polyangiitis(MPA) Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Microscopic Polyangiitis(MPA) Treatment Revenue in 2020
3.5 Microscopic Polyangiitis(MPA) Treatment Key Players Head office and Area Served
3.6 Key Players Microscopic Polyangiitis(MPA) Treatment Product Solution and Service
3.7 Date of Enter into Microscopic Polyangiitis(MPA) Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Microscopic Polyangiitis(MPA) Treatment Breakdown Data by Type
4.1 Global Microscopic Polyangiitis(MPA) Treatment Historic Market Size by Type (2016-2021)
4.2 Global Microscopic Polyangiitis(MPA) Treatment Forecasted Market Size by Type (2022-2027)

5 Microscopic Polyangiitis(MPA) Treatment Breakdown Data by Application
5.1 Global Microscopic Polyangiitis(MPA) Treatment Historic Market Size by Application (2016-2021)
5.2 Global Microscopic Polyangiitis(MPA) Treatment Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Microscopic Polyangiitis(MPA) Treatment Market Size (2016-2027)
6.2 North America Microscopic Polyangiitis(MPA) Treatment Market Size by Type
6.2.1 North America Microscopic Polyangiitis(MPA) Treatment Market Size by Type (2016-2021)
6.2.2 North America Microscopic Polyangiitis(MPA) Treatment Market Size by Type (2022-2027)
6.2.3 North America Microscopic Polyangiitis(MPA) Treatment Market Size by Type (2016-2027)
6.3 North America Microscopic Polyangiitis(MPA) Treatment Market Size by Application
6.3.1 North America Microscopic Polyangiitis(MPA) Treatment Market Size by Application (2016-2021)
6.3.2 North America Microscopic Polyangiitis(MPA) Treatment Market Size by Application (2022-2027)
6.3.3 North America Microscopic Polyangiitis(MPA) Treatment Market Size by Application (2016-2027)
6.4 North America Microscopic Polyangiitis(MPA) Treatment Market Size by Country
6.4.1 North America Microscopic Polyangiitis(MPA) Treatment Market Size by Country (2016-2021)
6.4.2 North America Microscopic Polyangiitis(MPA) Treatment Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Microscopic Polyangiitis(MPA) Treatment Market Size (2016-2027)
7.2 Europe Microscopic Polyangiitis(MPA) Treatment Market Size by Type
7.2.1 Europe Microscopic Polyangiitis(MPA) Treatment Market Size by Type (2016-2021)
7.2.2 Europe Microscopic Polyangiitis(MPA) Treatment Market Size by Type (2022-2027)
7.2.3 Europe Microscopic Polyangiitis(MPA) Treatment Market Size by Type (2016-2027)
7.3 Europe Microscopic Polyangiitis(MPA) Treatment Market Size by Application
7.3.1 Europe Microscopic Polyangiitis(MPA) Treatment Market Size by Application (2016-2021)
7.3.2 Europe Microscopic Polyangiitis(MPA) Treatment Market Size by Application (2022-2027)
7.3.3 Europe Microscopic Polyangiitis(MPA) Treatment Market Size by Application (2016-2027)
7.4 Europe Microscopic Polyangiitis(MPA) Treatment Market Size by Country
7.4.1 Europe Microscopic Polyangiitis(MPA) Treatment Market Size by Country (2016-2021)
7.4.2 Europe Microscopic Polyangiitis(MPA) Treatment Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Microscopic Polyangiitis(MPA) Treatment Market Size (2016-2027)
8.2 Asia-Pacific Microscopic Polyangiitis(MPA) Treatment Market Size by Type
8.2.1 Asia-Pacific Microscopic Polyangiitis(MPA) Treatment Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Microscopic Polyangiitis(MPA) Treatment Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Microscopic Polyangiitis(MPA) Treatment Market Size by Type (2016-2027)
8.3 Asia-Pacific Microscopic Polyangiitis(MPA) Treatment Market Size by Application
8.3.1 Asia-Pacific Microscopic Polyangiitis(MPA) Treatment Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Microscopic Polyangiitis(MPA) Treatment Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Microscopic Polyangiitis(MPA) Treatment Market Size by Application (2016-2027)
8.4 Asia-Pacific Microscopic Polyangiitis(MPA) Treatment Market Size by Region
8.4.1 Asia-Pacific Microscopic Polyangiitis(MPA) Treatment Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Microscopic Polyangiitis(MPA) Treatment Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Microscopic Polyangiitis(MPA) Treatment Market Size (2016-2027)
9.2 Latin America Microscopic Polyangiitis(MPA) Treatment Market Size by Type
9.2.1 Latin America Microscopic Polyangiitis(MPA) Treatment Market Size by Type (2016-2021)
9.2.2 Latin America Microscopic Polyangiitis(MPA) Treatment Market Size by Type (2022-2027)
9.2.3 Latin America Microscopic Polyangiitis(MPA) Treatment Market Size by Type (2016-2027)
9.3 Latin America Microscopic Polyangiitis(MPA) Treatment Market Size by Application
9.3.1 Latin America Microscopic Polyangiitis(MPA) Treatment Market Size by Application (2016-2021)
9.3.2 Latin America Microscopic Polyangiitis(MPA) Treatment Market Size by Application (2022-2027)
9.3.3 Latin America Microscopic Polyangiitis(MPA) Treatment Market Size by Application (2016-2027)
9.4 Latin America Microscopic Polyangiitis(MPA) Treatment Market Size by Country
9.4.1 Latin America Microscopic Polyangiitis(MPA) Treatment Market Size by Country (2016-2021)
9.4.2 Latin America Microscopic Polyangiitis(MPA) Treatment Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Microscopic Polyangiitis(MPA) Treatment Market Size (2016-2027)
10.2 Middle East & Africa Microscopic Polyangiitis(MPA) Treatment Market Size by Type
10.2.1 Middle East & Africa Microscopic Polyangiitis(MPA) Treatment Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Microscopic Polyangiitis(MPA) Treatment Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Microscopic Polyangiitis(MPA) Treatment Market Size by Type (2016-2027)
10.3 Middle East & Africa Microscopic Polyangiitis(MPA) Treatment Market Size by Application
10.3.1 Middle East & Africa Microscopic Polyangiitis(MPA) Treatment Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Microscopic Polyangiitis(MPA) Treatment Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Microscopic Polyangiitis(MPA) Treatment Market Size by Application (2016-2027)
10.4 Middle East & Africa Microscopic Polyangiitis(MPA) Treatment Market Size by Country
10.4.1 Middle East & Africa Microscopic Polyangiitis(MPA) Treatment Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Microscopic Polyangiitis(MPA) Treatment Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Celltrion Inc
11.1.1 Celltrion Inc Company Details
11.1.2 Celltrion Inc Business Overview
11.1.3 Celltrion Inc Microscopic Polyangiitis(MPA) Treatment Introduction
11.1.4 Celltrion Inc Revenue in Microscopic Polyangiitis(MPA) Treatment Business (2016-2021)
11.1.5 Celltrion Inc Recent Development
11.2 ChemoCentryx Inc
11.2.1 ChemoCentryx Inc Company Details
11.2.2 ChemoCentryx Inc Business Overview
11.2.3 ChemoCentryx Inc Microscopic Polyangiitis(MPA) Treatment Introduction
11.2.4 ChemoCentryx Inc Revenue in Microscopic Polyangiitis(MPA) Treatment Business (2016-2021)
11.2.5 ChemoCentryx Inc Recent Development
11.3 Sandoz International GmbH
11.3.1 Sandoz International GmbH Company Details
11.3.2 Sandoz International GmbH Business Overview
11.3.3 Sandoz International GmbH Microscopic Polyangiitis(MPA) Treatment Introduction
11.3.4 Sandoz International GmbH Revenue in Microscopic Polyangiitis(MPA) Treatment Business (2016-2021)
11.3.5 Sandoz International GmbH Recent Development
11.4 Teijin Pharma Ltd
11.4.1 Teijin Pharma Ltd Company Details
11.4.2 Teijin Pharma Ltd Business Overview
11.4.3 Teijin Pharma Ltd Microscopic Polyangiitis(MPA) Treatment Introduction
11.4.4 Teijin Pharma Ltd Revenue in Microscopic Polyangiitis(MPA) Treatment Business (2016-2021)
11.4.5 Teijin Pharma Ltd Recent Development
11.5 TTY Biopharm Company Ltd
11.5.1 TTY Biopharm Company Ltd Company Details
11.5.2 TTY Biopharm Company Ltd Business Overview
11.5.3 TTY Biopharm Company Ltd Microscopic Polyangiitis(MPA) Treatment Introduction
11.5.4 TTY Biopharm Company Ltd Revenue in Microscopic Polyangiitis(MPA) Treatment Business (2016-2021)
11.5.5 TTY Biopharm Company Ltd Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Microscopic Polyangiitis(MPA) Treatment Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Avacopan
Table 3. Key Players of Immune Globulin
Table 4. Key Players of Rituximab Biosimilar
Table 5. Key Players of Others
Table 6. Global Microscopic Polyangiitis(MPA) Treatment Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Microscopic Polyangiitis(MPA) Treatment Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Microscopic Polyangiitis(MPA) Treatment Market Size by Regions (2016-2021) & (US$ Million)
Table 9. Global Microscopic Polyangiitis(MPA) Treatment Market Share by Regions (2016-2021)
Table 10. Global Microscopic Polyangiitis(MPA) Treatment Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 11. Global Microscopic Polyangiitis(MPA) Treatment Market Share by Regions (2022-2027)
Table 12. Microscopic Polyangiitis(MPA) Treatment Market Trends
Table 13. Microscopic Polyangiitis(MPA) Treatment Market Drivers
Table 14. Microscopic Polyangiitis(MPA) Treatment Market Challenges
Table 15. Microscopic Polyangiitis(MPA) Treatment Market Restraints
Table 16. Global Microscopic Polyangiitis(MPA) Treatment Revenue by Players (2016-2021) & (US$ Million)
Table 17. Global Microscopic Polyangiitis(MPA) Treatment Market Share by Players (2016-2021)
Table 18. Global Top Microscopic Polyangiitis(MPA) Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Microscopic Polyangiitis(MPA) Treatment as of 2020)
Table 19. Ranking of Global Top Microscopic Polyangiitis(MPA) Treatment Companies by Revenue (US$ Million) in 2020
Table 20. Global 5 Largest Players Market Share by Microscopic Polyangiitis(MPA) Treatment Revenue (CR5 and HHI) & (2016-2021)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Microscopic Polyangiitis(MPA) Treatment Product Solution and Service
Table 23. Date of Enter into Microscopic Polyangiitis(MPA) Treatment Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Microscopic Polyangiitis(MPA) Treatment Market Size by Type (2016-2021) (US$ Million)
Table 26. Global Microscopic Polyangiitis(MPA) Treatment Revenue Market Share by Type (2016-2021)
Table 27. Global Microscopic Polyangiitis(MPA) Treatment Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 28. Global Microscopic Polyangiitis(MPA) Treatment Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 29. Global Microscopic Polyangiitis(MPA) Treatment Market Size Share by Application (2016-2021) & (US$ Million)
Table 30. Global Microscopic Polyangiitis(MPA) Treatment Revenue Market Share by Application (2016-2021)
Table 31. Global Microscopic Polyangiitis(MPA) Treatment Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 32. Global Microscopic Polyangiitis(MPA) Treatment Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 33. North America Microscopic Polyangiitis(MPA) Treatment Market Size by Type (2016-2021) (US$ Million)
Table 34. North America Microscopic Polyangiitis(MPA) Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 35. North America Microscopic Polyangiitis(MPA) Treatment Market Size by Application (2016-2021) (US$ Million)
Table 36. North America Microscopic Polyangiitis(MPA) Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 37. North America Microscopic Polyangiitis(MPA) Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 38. North America Microscopic Polyangiitis(MPA) Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 39. Europe Microscopic Polyangiitis(MPA) Treatment Market Size by Type (2016-2021) (US$ Million)
Table 40. Europe Microscopic Polyangiitis(MPA) Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 41. Europe Microscopic Polyangiitis(MPA) Treatment Market Size by Application (2016-2021) (US$ Million)
Table 42. Europe Microscopic Polyangiitis(MPA) Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 43. Europe Microscopic Polyangiitis(MPA) Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 44. Europe Microscopic Polyangiitis(MPA) Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Microscopic Polyangiitis(MPA) Treatment Market Size by Type (2016-2021) (US$ Million)
Table 46. Asia-Pacific Microscopic Polyangiitis(MPA) Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Microscopic Polyangiitis(MPA) Treatment Market Size by Application (2016-2021) (US$ Million)
Table 48. Asia-Pacific Microscopic Polyangiitis(MPA) Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 49. Asia-Pacific Microscopic Polyangiitis(MPA) Treatment Market Size by Region (2016-2021) & (US$ Million)
Table 50. Asia-Pacific Microscopic Polyangiitis(MPA) Treatment Market Size by Region (2022-2027) & (US$ Million)
Table 51. Latin America Microscopic Polyangiitis(MPA) Treatment Market Size by Type (2016-2021) (US$ Million)
Table 52. Latin America Microscopic Polyangiitis(MPA) Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 53. Latin America Microscopic Polyangiitis(MPA) Treatment Market Size by Application (2016-2021) (US$ Million)
Table 54. Latin America Microscopic Polyangiitis(MPA) Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 55. Latin America Microscopic Polyangiitis(MPA) Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 56. Latin America Microscopic Polyangiitis(MPA) Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Microscopic Polyangiitis(MPA) Treatment Market Size by Type (2016-2021) (US$ Million)
Table 58. Middle East & Africa Microscopic Polyangiitis(MPA) Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Microscopic Polyangiitis(MPA) Treatment Market Size by Application (2016-2021) (US$ Million)
Table 60. Middle East & Africa Microscopic Polyangiitis(MPA) Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 61. Middle East & Africa Microscopic Polyangiitis(MPA) Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 62. Middle East & Africa Microscopic Polyangiitis(MPA) Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 63. Celltrion Inc Company Details
Table 64. Celltrion Inc Business Overview
Table 65. Celltrion Inc Microscopic Polyangiitis(MPA) Treatment Product
Table 66. Celltrion Inc Revenue in Microscopic Polyangiitis(MPA) Treatment Business (2016-2021) & (US$ Million)
Table 67. Celltrion Inc Recent Development
Table 68. ChemoCentryx Inc Company Details
Table 69. ChemoCentryx Inc Business Overview
Table 70. ChemoCentryx Inc Microscopic Polyangiitis(MPA) Treatment Product
Table 71. ChemoCentryx Inc Revenue in Microscopic Polyangiitis(MPA) Treatment Business (2016-2021) & (US$ Million)
Table 72. ChemoCentryx Inc Recent Development
Table 73. Sandoz International GmbH Company Details
Table 74. Sandoz International GmbH Business Overview
Table 75. Sandoz International GmbH Microscopic Polyangiitis(MPA) Treatment Product
Table 76. Sandoz International GmbH Revenue in Microscopic Polyangiitis(MPA) Treatment Business (2016-2021) & (US$ Million)
Table 77. Sandoz International GmbH Recent Development
Table 78. Teijin Pharma Ltd Company Details
Table 79. Teijin Pharma Ltd Business Overview
Table 80. Teijin Pharma Ltd Microscopic Polyangiitis(MPA) Treatment Product
Table 81. Teijin Pharma Ltd Revenue in Microscopic Polyangiitis(MPA) Treatment Business (2016-2021) & (US$ Million)
Table 82. Teijin Pharma Ltd Recent Development
Table 83. TTY Biopharm Company Ltd Company Details
Table 84. TTY Biopharm Company Ltd Business Overview
Table 85. TTY Biopharm Company Ltd Microscopic Polyangiitis(MPA) Treatment Product
Table 86. TTY Biopharm Company Ltd Revenue in Microscopic Polyangiitis(MPA) Treatment Business (2016-2021) & (US$ Million)
Table 87. TTY Biopharm Company Ltd Recent Development
Table 88. Research Programs/Design for This Report
Table 89. Key Data Information from Secondary Sources
Table 90. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Microscopic Polyangiitis(MPA) Treatment Market Share by Type: 2020 VS 2027
Figure 2. Avacopan Features
Figure 3. Immune Globulin Features
Figure 4. Rituximab Biosimilar Features
Figure 5. Others Features
Figure 6. Global Microscopic Polyangiitis(MPA) Treatment Market Share by Application: 2020 VS 2027
Figure 7. Hospital Case Studies
Figure 8. Clinic Case Studies
Figure 9. Others Case Studies
Figure 10. Microscopic Polyangiitis(MPA) Treatment Report Years Considered
Figure 11. Global Microscopic Polyangiitis(MPA) Treatment Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 12. Global Microscopic Polyangiitis(MPA) Treatment Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 13. Global Microscopic Polyangiitis(MPA) Treatment Market Share by Regions: 2020 VS 2027
Figure 14. Global Microscopic Polyangiitis(MPA) Treatment Market Share by Regions (2022-2027)
Figure 15. Global Microscopic Polyangiitis(MPA) Treatment Market Share by Players in 2020
Figure 16. Global Top Microscopic Polyangiitis(MPA) Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Microscopic Polyangiitis(MPA) Treatment as of 2020
Figure 17. The Top 10 and 5 Players Market Share by Microscopic Polyangiitis(MPA) Treatment Revenue in 2020
Figure 18. Global Microscopic Polyangiitis(MPA) Treatment Revenue Market Share by Type (2016-2021)
Figure 19. Global Microscopic Polyangiitis(MPA) Treatment Revenue Market Share by Type (2022-2027)
Figure 20. North America Microscopic Polyangiitis(MPA) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 21. North America Microscopic Polyangiitis(MPA) Treatment Market Share by Type (2016-2027)
Figure 22. North America Microscopic Polyangiitis(MPA) Treatment Market Share by Application (2016-2027)
Figure 23. North America Microscopic Polyangiitis(MPA) Treatment Market Share by Country (2016-2027)
Figure 24. United States Microscopic Polyangiitis(MPA) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Canada Microscopic Polyangiitis(MPA) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Microscopic Polyangiitis(MPA) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Microscopic Polyangiitis(MPA) Treatment Market Share by Type (2016-2027)
Figure 28. Europe Microscopic Polyangiitis(MPA) Treatment Market Share by Application (2016-2027)
Figure 29. Europe Microscopic Polyangiitis(MPA) Treatment Market Share by Country (2016-2027)
Figure 30. Germany Microscopic Polyangiitis(MPA) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. France Microscopic Polyangiitis(MPA) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. U.K. Microscopic Polyangiitis(MPA) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Italy Microscopic Polyangiitis(MPA) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Russia Microscopic Polyangiitis(MPA) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Nordic Microscopic Polyangiitis(MPA) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Microscopic Polyangiitis(MPA) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Microscopic Polyangiitis(MPA) Treatment Market Share by Type (2016-2027)
Figure 38. Asia-Pacific Microscopic Polyangiitis(MPA) Treatment Market Share by Application (2016-2027)
Figure 39. Asia-Pacific Microscopic Polyangiitis(MPA) Treatment Market Share by Region (2016-2027)
Figure 40. China Microscopic Polyangiitis(MPA) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Japan Microscopic Polyangiitis(MPA) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. South Korea Microscopic Polyangiitis(MPA) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Southeast Asia Microscopic Polyangiitis(MPA) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. India Microscopic Polyangiitis(MPA) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Australia Microscopic Polyangiitis(MPA) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Microscopic Polyangiitis(MPA) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Microscopic Polyangiitis(MPA) Treatment Market Share by Type (2016-2027)
Figure 48. Latin America Microscopic Polyangiitis(MPA) Treatment Market Share by Application (2016-2027)
Figure 49. Latin America Microscopic Polyangiitis(MPA) Treatment Market Share by Country (2016-2027)
Figure 50. Mexico Microscopic Polyangiitis(MPA) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Brazil Microscopic Polyangiitis(MPA) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Microscopic Polyangiitis(MPA) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Microscopic Polyangiitis(MPA) Treatment Market Share by Type (2016-2027)
Figure 54. Middle East & Africa Microscopic Polyangiitis(MPA) Treatment Market Share by Application (2016-2027)
Figure 55. Middle East & Africa Microscopic Polyangiitis(MPA) Treatment Market Share by Country (2016-2027)
Figure 56. Turkey Microscopic Polyangiitis(MPA) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Saudi Arabia Microscopic Polyangiitis(MPA) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. UAE Microscopic Polyangiitis(MPA) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. Celltrion Inc Revenue Growth Rate in Microscopic Polyangiitis(MPA) Treatment Business (2016-2021)
Figure 60. ChemoCentryx Inc Revenue Growth Rate in Microscopic Polyangiitis(MPA) Treatment Business (2016-2021)
Figure 61. Sandoz International GmbH Revenue Growth Rate in Microscopic Polyangiitis(MPA) Treatment Business (2016-2021)
Figure 62. Teijin Pharma Ltd Revenue Growth Rate in Microscopic Polyangiitis(MPA) Treatment Business (2016-2021)
Figure 63. TTY Biopharm Company Ltd Revenue Growth Rate in Microscopic Polyangiitis(MPA) Treatment Business (2016-2021)
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Figure 66. Key Executives Interviewed

以下、関連資料のご紹介

世界の結核（TB）治療市場規模・現状・予測（2021年-2027年）

Global Tuberculosis (TB) Treatment Market Size, Status and Forecast 2021-2027
QFJ1-4987 2021年6月 95Pages
QYResearch社発行の本調査レポートでは、結核（TB）治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（イソニアジド、リファンピン（リファディン、リマクタン）、エタンブトール（ミアンブトール）、ピラジナミド）、用途別市場規模（活動性結核、潜...

世界の尿素サイクル異常症（UCD）治療市場規模・現状・予測（2021年-2027年）

Global Urea Cycle Disorders (UCD) Treatment Market Size, Status and Forecast 2021-2027
QFJ1-5000 2021年6月 88Pages
QYResearch社発行の本調査レポートでは、尿素サイクル異常症（UCD）治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（アミノ酸式、フェニル酪酸、安息香酸ナトリウム、その他）、用途別市場規模（病院薬局、小売薬局、オンライン薬局）、主要地域別...

世界の原始神経外胚葉性腫瘍（PNET）治療市場規模・現状・予測（2021年-2027年）

Global Primitive Neuroectodermal Tumors (PNET) Treatment Market Size, Status and Forecast 2021-2027
QFJ1-4766 2021年6月 98Pages
QYResearch社発行の本調査レポートでは、原始神経外胚葉性腫瘍（PNET）治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（外科手術、化学療法、放射線療法）、用途別市場規模（病院、外来手術センター、その他）、主要地域別市場規模（北米、アメリ...

世界の慢性難治性咳（CRC）治療市場規模・現状・予測（2021年-2027年）

Global Chronic Refractory Cough (CRC) Treatment Market Size, Status and Forecast 2021-2027
QFJ1-5661 2021年6月 95Pages
QYResearch社発行の本調査レポートでは、慢性難治性咳（CRC）治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（言語療法、理学療法）、用途別市場規模（病院、診療所、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓...

世界の骨髄性プロトポルフィリン症（EPP）治療市場規模・現状・予測（2021年-2027年）

Global Erythropoietic Protoporphyria (EPP) Treatment Market Size, Status and Forecast 2021-2027
QFJ1-4205 2021年6月 97Pages
QYResearch社発行の本調査レポートでは、骨髄性プロトポルフィリン症（EPP）治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（ホルモン療法、補助療法、光線療法）、用途別市場規模（病院薬局、ドラッグストア、小売薬局、オンライン薬局）、主要地...

世界のB細胞非ホジキンリンパ腫（NHL）治療市場規模・現状・予測（2021年-2027年）

Global B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Size, Status and Forecast 2021-2027
QFJ1-3894 2021年6月 100Pages
QYResearch社発行の本調査レポートでは、B細胞非ホジキンリンパ腫（NHL）治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（化学療法、放射線療法、その他）、用途別市場規模（病院、診療所、外来手術センター、その他）、主要地域別市場規模（北米...

世界の乳腺線維嚢胞診断＆治療市場規模・現状・予測（2021年-2027年）

Global Fibrocystic Breasts Diagnostics and Treatment Market Size, Status and Forecast 2021-2027
QFJ1-4225 2021年6月 96Pages
QYResearch社発行の本調査レポートでは、乳腺線維嚢胞診断＆治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（診断、治療）、用途別市場規模（病院、診療所、診断センター、研究所、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本...

世界の重症筋無力症（MG）治療市場規模・現状・予測（2021年-2027年）

Global Myasthenia Gravis (MG) Treatment Market Size, Status and Forecast 2021-2027
QFJ1-4538 2021年6月 108Pages
QYResearch社発行の本調査レポートでは、重症筋無力症（MG）治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（薬物治療、迅速免疫療法、その他）、用途別市場規模（病院・クリニック、診断センター、学術・研究機関）、主要地域別市場規模（北米、ア...

世界の顧みられない熱帯病（NTD）治療市場規模・現状・予測（2021年-2027年）

Global Neglected Tropical Disease (NTD) Treatment Market Size, Status and Forecast 2021-2027
QFJ1-4558 2021年6月 107Pages
QYResearch社発行の本調査レポートでは、顧みられない熱帯病（NTD）治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（治療薬、ワクチン）、用途別市場規模（病院・クリニック、診断センター、学術・研究機関）、主要地域別市場規模（北米、アメリカ...

世界の非アルコール性脂肪性肝炎（NASH）治療市場規模・現状・予測（2021年-2027年）

Global Non-Alcoholic Steatohepatitis (NASH) Treatment Market Size, Status and Forecast 2021-2027
QFJ1-4586 2021年6月 99Pages
QYResearch社発行の本調査レポートでは、非アルコール性脂肪性肝炎（NASH）治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（保険適用外、治療）、用途別市場規模（病院薬局、オンラインプロバイダー、小売薬局）、主要地域別市場規模（北米、アメ...

世界の非薬物式うつ病治療市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Drug Free Depression Treatment Market The global Drug Free Depression Treatment market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analysis and high data int…
世界の血管損傷治療市場規模・現状・予測（2021年-2027年） The term "vascular trauma" refers to injury to a blood vessel—an artery, which carries blood to an extremity or an organ, or a vein, which returns blood to the heart. Vascular Surgeons categorize these injuries by the type of trauma that caused them: blunt or penetrating injury. Market Analysis and …
顕微鏡照明装置のグローバル市場調査 2019年 The global Microscopic Illumination Equipments market was valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. This report focuses on Microscopic Illumination Equipments volume and value at global level, regional level and comp…
世界の破壊的行動障害（DBD）治療市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Disruptive Behavior Disorder (DBD) Treatment Market The global Disruptive Behavior Disorder (DBD) Treatment market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy i…
世界の子宮内人工授精（IUI）治療市場規模・現状・予測（2021年-2027年） Intrauterine Insemination (IUI) a type of artificial insemination is a procedure for treating infertility. Sperm that have been washed and concentrated are placed directly in your uterus around the time your ovary releases one or more eggs to be fertilized.IUI also sometimes called donor inseminatio…